The silent epidemic of non-adherence – insights from the 2024 a:care congress

被引：0

作者：

Sheri D. Pruitt ^{[1
]}

Rabia Khan ^{[2
]}

Nathorn Chaiyakunapruk ^{[3
]}

Arintaya Phrommintikul ^{[4
]}

Miguel Angel Díaz Aguilera ^{[5
]}

Ngiap Chuan Tan ^{[6
]}

Shoaib Afzal ^{[7
]}

Andressa da Silva van der Laan ^{[8
]}

John Weinman ^{[9
]}

机构：

[1] Independent Behavioral Science Consultant,Former Director of Behavioral Science Integration

[2] University of New South Wales,School of Population Health

[3] University of Utah,Department of Pharmacotherapy, College of Pharmacy

[4] Chiang Mai University,Division of Cardiology, Department of Internal Medicine, Faculty of Medicine

[5] Ministry of Health,National Center for Preventive Programs and Disease Control

[6] SingHealth Polyclinics,Department of Clinical Biochemistry

[7] Duke NUS Medical School, Global Innovation and Development

[8] Copenhagen University Hospital Herlev and Gentofte,Institute of Pharmaceutical Science

[9] Abbott Product Operations AG,undefined

[10] King’s College London,undefined

来源：

BMC Proceedings | / 19卷 / Suppl 10期

关键词：

Medication adherence; Non-adherence; Congress; Behavioral science; Behavior patient-physician relationships; Health economics; Digital health technologies; Adherence stakeholders;

D O I：

10.1186/s12919-025-00326-4

中图分类号：

学科分类号：

摘要：

Medication non-adherence is a global challenge with profound implications for patient health outcomes, healthcare systems, and society at large. This widespread issue leads to hundreds of thousands of preventable deaths and hospitalizations annually, and billions of dollars in avoidable healthcare costs. No country is immune to this challenge. The a:care Congress 2024, titled "Adherence is a Behavior: Do We Have the Right One?", addressed this critical issue to understand its societal and economic burden and explore the complex human behaviors driving it. The Congress examined the global impact of non-adherence and local realities, providing a health economic perspective on its consequences. Behavioral factors influencing adherence were analyzed, emphasizing the importance of understanding individual patient motivations. The role of technology and artificial intelligence in the physician–patient relationship was discussed, highlighting opportunities and challenges of integrating these tools. The patient's voice was brought to the forefront, underscoring the importance of communication and trust in the care relationship. A final multidisciplinary session explored the role of each stakeholder in improving adherence. This article provides an overview of the different sessions from the congress, focusing on the challenges associated with medication non-adherence and potential solutions. It emphasizes the need for a multidimensional approach involving all healthcare system stakeholders and the importance of prioritizing the development of new strategies to improve overall health outcomes and healthcare system efficiency.

引用